Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102037445 | 10203744 | 5 | F | 2012 | 20141119 | 20140529 | 20160808 | EXP | PHHY2012JP106550 | NOVARTIS | 72.54 | YR | M | Y | 83.00000 | KG | 20160808 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102037445 | 10203744 | 1 | PS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | 890 | MG | 22334 | 10 | MG | TABLET | QD | ||||
| 102037445 | 10203744 | 2 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | 890 | MG | 22334 | 10 | MG | TABLET | QD | ||||
| 102037445 | 10203744 | 3 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 5 MG, QD | 890 | MG | 22334 | 5 | MG | TABLET | QD | ||||
| 102037445 | 10203744 | 4 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | Y | 0 | ||||||||||
| 102037445 | 10203744 | 5 | C | LOXOPROFEN | LOXOPROFEN | 1 | Oral | 60 MG, UNK | U | U | 0 | 60 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102037445 | 10203744 | 1 | Pancreatic neuroendocrine tumour |
| 102037445 | 10203744 | 4 | Pancreatic neuroendocrine tumour |
| 102037445 | 10203744 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102037445 | 10203744 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102037445 | 10203744 | Anaemia | |
| 102037445 | 10203744 | Bile duct stone | |
| 102037445 | 10203744 | Blood albumin decreased | |
| 102037445 | 10203744 | Blood lactate dehydrogenase increased | |
| 102037445 | 10203744 | C-reactive protein increased | |
| 102037445 | 10203744 | Diarrhoea | |
| 102037445 | 10203744 | Hepatic function abnormal | |
| 102037445 | 10203744 | Interstitial lung disease | |
| 102037445 | 10203744 | Oedema peripheral | |
| 102037445 | 10203744 | Platelet count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102037445 | 10203744 | 1 | 20120426 | 20120723 | 0 | |
| 102037445 | 10203744 | 2 | 20120910 | 20120918 | 0 | |
| 102037445 | 10203744 | 3 | 20130919 | 0 | ||
| 102037445 | 10203744 | 4 | 20100607 | 20120416 | 0 | |
| 102037445 | 10203744 | 5 | 20120901 | 20120902 | 0 |